Delivery Order SPE2DR25D1202-SPE2DR26F71PD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) under a firm fixed-price contract type. The award, issued on October 29, 2025, with an ultimate completion date of October 30, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a delivery order valued at $1,697.60 to AmerisourceBergen Drug Corp for VISCOAT Syringe 0.5ML on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The award represents a small-value...
- The Defense Logistics Agency awarded a $9,100.35 delivery order to AmerisourceBergen Drug Corp for VISCOAT syringes (0.5mL) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that runs through December 2026. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,527.85 firm fixed price delivery order contract to provide VISCOAT SYRINGE 0.5ML. The contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,500.68 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5ML) under a firm fixed-price contract type. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VISCOAT syringes (0.5ml) valued at $3,483.35 under a firm fixed-price contract type. The award, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.5 mL VISCOAT syringes. The $5,065.40 firm-fixed-price contract has a completion date of May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.75 to AmerisourceBergen Drug Corp for 0.5mL Viscoat syringes, with an ultimate completion date of August 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office based in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,628.99 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Viscoat syringes (0.5mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71PDDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,109.08 delivery order to AmerisourceBergen Drug Corp for VISCOAT Syringe 0.5ML, with an ultimate completion date of October 23, 2025. This firm fixed-price contract, awarded on October 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award utilized no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits—to support military healthcare programs worldwide. Through this prime contract vehicle, the company serves customers including the Defense Health Agency and the U.S. Coast Guard, demonstrating its capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 10/22/25 |